Sequenom CEO Buys $97K Worth of Co.'s Stock This Month As Shares Rally | GenomeWeb
NEW YORK (GenomeWeb News) - Sequenom CEO Harry Stylli bought 13,313 shares of the company's stock at an average price of $1.86 per share for total proceeds of $24,964 on Aug. 11, according to documents filed with the Securities and Exchange Commission.
 
Since Aug. 7, he purchased 53,700 shares for total proceeds of $96,565. He currently owns 54,700 shares of Sequenom stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.